Therefore, it's unclear if the improvements were due to BPC 157 or simply the passage of time
A systematic review of prolotherapy for chronic musculoskeletal pain
Stacking Options for Enhanced Recovery Combining BPC-157 with other peptides or compounds can enhance outcomes for severe or stubborn injuries
There are still no clinical trials
FDAs Pharmacy Compounding Advisory Committee (PCAC) review of seven peptides for potential inclusion on the 503A Bulks List is scheduled for July 2324, 2026
Serial investor Michael Carter, who has founded and run various gaming and software startups, recently started a company called Finnrick, which he says is "creating the market force for these vendors to care about safety." He said most of the retatrutide samples he has tested are the real deal, the "exact same thing" that Eli Lilly is making, but there's really no way to be totally sure